Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-02-22 @ 4:59 PM
Study NCT ID:
NCT04195958
Status:
TERMINATED
Last Update Posted:
2022-03-15
First Post:
2019-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-09
First Submit QC Date:
None
Study First Post Date:
2019-12-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-01-07
Results First Submit QC Date:
None
Results First Post Date:
2022-03-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-16
Last Update Post Date:
2022-03-15
Last Update Post Date Type:
ACTUAL